For instance, a study identified the HER2 pathway in breast cancer as a potential driver of pulmonary fibroblast invasion, highlighting its relevance as a target for idiopathic pulmonary fibrosis treatment and intervention (Liu et al., 2022). The gene discussed is ERBB2; the disease is idiopathic pulmonary fibrosis.